{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:31:35Z","timestamp":1767850295299,"version":"3.49.0"},"reference-count":24,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T00:00:00Z","timestamp":1698105600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"accepted":{"date-parts":[[2023,10,2]]},"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>To determine the baseline trends in the total birth prevalence of neural tube defects (NTDs) in England (2000\u20132019) to enable the impact of folic acid fortification of non-wholemeal wheat flour to be monitored.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Population-based, observational study using congenital anomaly (CA) registration data for England curated by the National Congenital Anomaly and Rare Disease Registration Service (NCARDRS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>Regions of England with active registration in the time period.<\/jats:p><\/jats:sec><jats:sec><jats:title>Participants<\/jats:title><jats:p>Babies that were liveborn or stillborn and pregnancies that resulted in a termination of pregnancy or a late miscarriage (20\u201323 weeks\u2019 gestation) with an NTD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main outcome measures<\/jats:title><jats:p>Total birth prevalence of anencephaly, spina bifida and all NTDs in England. Poisson regression analysis was used to evaluate time trends with regional register as a random effect. The progress of national registration across England was assessed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There were 4541 NTD pregnancies out of 3\u2009637\u2009842 births in England; 1982 anencephaly and 2127 spina bifida. NTD prevalence was 12.5 (95% CI 12.1 to 12.9) per 10\u2009000 total births. NTD prevalence per 10\u2009000 total births was significantly higher in 2015\u20132019 (13.6, 95%\u2009CI 12.9 to 14.4) compared with 2010\u20132014 (12.1, 95%\u2009CI 11.7 to 12.5). An increasing trend in NTDs overall was detected (incidence rate ratio (IRR) 1.01, 1.00 to 1.02), although further analysis determined this effect was confined to 2015\u20132019 (compared against 2000\u20132004, IRR 1.14, 1.04 to 1.24). The birth prevalence of anencephaly reflected this pattern. The prevalence of spina bifida remained relatively stable over time.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Baseline NTD prevalence for England has been established. National and standardised CA registration is in place, facilitating the systematic and consistent monitoring of pre-fortification and post-fortification NTD trends and evaluating the impact of fortification on NTD prevalence.<\/jats:p><\/jats:sec>","DOI":"10.1136\/archdischild-2023-325856","type":"journal-article","created":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T17:23:27Z","timestamp":1698168207000},"page":"106-112","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Prevalence of neural tube defects in England prior to the mandatory fortification of non-wholemeal wheat flour with folic acid: a population-based cohort study"],"prefix":"10.1136","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4450-2147","authenticated-orcid":false,"given":"Jennifer M","family":"Broughan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gillian","family":"Swan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrienne","family":"Cullum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer J","family":"Kurinczuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9340-8176","authenticated-orcid":false,"given":"Elizabeth S","family":"Draper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9806-1092","authenticated-orcid":false,"given":"Karen","family":"Luyt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana G","family":"Wellesley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Tedstone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Rankin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,10,24]]},"reference":[{"key":"2024110504301036000_109.2.106.1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-neuro-062012-170354"},{"key":"2024110504301036000_109.2.106.2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90133-A"},{"key":"2024110504301036000_109.2.106.3","unstructured":"Public Health England . Health of women before and during pregnancy: health behaviours, risk factors and inequalities; 2019."},{"key":"2024110504301036000_109.2.106.4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ypmed.2018.05.023","article-title":"Folic acid supplementation during the preconception period: a systematic review and meta-analysis","volume":"114","author":"Toivonen","year":"2018","journal-title":"Prev Med"},{"key":"2024110504301036000_109.2.106.5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194986","article-title":"Trends in congenital anomalies in Europe from 1980 to 2012","volume":"13","author":"Morris","year":"2018","journal-title":"PLoS One"},{"key":"2024110504301036000_109.2.106.6","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h5949","article-title":"Long term trends in prevalence of neural tube defects in Europe: population based study","volume":"351","author":"Khoshnood","year":"2015","journal-title":"BMJ"},{"key":"2024110504301036000_109.2.106.7","unstructured":"Public Health England . National diet and nutrition survey. years 1 to 9 of the rolling programme (2008\/2009\u20132016\/2017): time trend and income analyses; 2019."},{"key":"2024110504301036000_109.2.106.8","doi-asserted-by":"publisher","DOI":"10.1017\/S1368980012003576"},{"key":"2024110504301036000_109.2.106.9","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s00381-022-05823-x","article-title":"Mandatory fortification with folic acid for the prevention of neural tube defects: a case study of Australia and New Zealand","volume":"39","author":"Thurston","year":"2023","journal-title":"Childs Nerv Syst"},{"key":"2024110504301036000_109.2.106.10","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.647038","article-title":"Prevention of neural tube defects in Europe: a public health failure","volume":"9","author":"Morris","year":"2021","journal-title":"Front Pediatr"},{"key":"2024110504301036000_109.2.106.11","unstructured":"Folic acid added to flour to prevent spinal conditions in babies [press release]. 2021. Available: https:\/\/www.gov.uk\/government\/news\/folic-acid-added-to-flour-to-prevent-brain-and-spinal-conditions-in-foetuses"},{"key":"2024110504301036000_109.2.106.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02134-6"},{"key":"2024110504301036000_109.2.106.13","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2017-312833"},{"key":"2024110504301036000_109.2.106.14","unstructured":"NCARDRS . National Congenital Anomaly and Rare Disease Registration Service Congenital Anomaly Statistics Report 2018. Report No.: PHE publications gateway number: GW-1445. UK Government: Public Health England; 2020."},{"key":"2024110504301036000_109.2.106.15","unstructured":"EUROCAT . EUROCAT guide 1.4: instruction for the registration of congenital anomalies. University of Ulster; 2013."},{"key":"2024110504301036000_109.2.106.16","unstructured":"Aldridge N , Pandya P , Rankin J , et al . Fetal anomaly ultrasound scan detection rates in England for 14 physical conditions; a three-year national cohort study; 2022."},{"key":"2024110504301036000_109.2.106.17","doi-asserted-by":"publisher","DOI":"10.1002\/wdev.71"},{"key":"2024110504301036000_109.2.106.18","first-page":"S23","article-title":"Paper 3: EUROCAT data quality indicators for population-based registries of congenital anomalies","volume":"91 Suppl 1","author":"Loane","year":"2011","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"2024110504301036000_109.2.106.19","unstructured":"Mayer CD , Craig L , Horgan G . Stochastic Modelling to estimate the potential impact of Fortification of flour with folic acid in the UK. Food Standards Scotland; 2017."},{"key":"2024110504301036000_109.2.106.20","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2018-316733"},{"key":"2024110504301036000_109.2.106.21","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2015-309226"},{"key":"2024110504301036000_109.2.106.22","unstructured":"Hilder L . Neural tube defects in Australia, 2007\u20132011: before and after mandatory folic acid Fortification. National Perinatal Epidemiology and Statistics Unit, University of New South Wales; 2016."},{"key":"2024110504301036000_109.2.106.23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.23.2981"},{"key":"2024110504301036000_109.2.106.24","doi-asserted-by":"publisher","DOI":"10.1016\/S1701-2163(16)32227-7"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2023-325856","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T12:32:19Z","timestamp":1730809939000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2023-325856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,24]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1,22]]},"published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1136\/archdischild-2023-325856"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2023-325856","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,24]]}}}